1439P Brain radiotherapy combined with camrelizumab and platinum-based chemotherapy as first-line treatment for advanced NSCLC with brain metastases: A multicenter, open-label, single-arm, phase II study

• DOI: 10.1016/j.annonc.2023.09.2470
• Publication Date: 2023-10-20T13:03:38Z
• Authors: Y. Fan; Y. Xu; Z. Huang; Y. Xu; L. Sheng; H. Li; H. Lu; K. Chen; S. Yu; L. Gong; N. Han; X. Xu; J. Qin; F. Xie; W. Hong; D. Huang; J. Chen
• Keywords: Open label